Thomas A. Hensing - Concepedia

Author

Thomas A. Hensing

Also Known As

Detterbeck, Frank, Gettinger, Scott, Hensing, Thomas A., McElroy, Edwin, T. A. Hensing, T. Hensing, T.A Hensing, T.A. Hensing, THOMAS A. HENSING, Thomas A Hensing

123

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

NorthShore University HealthSystem Northwestern University University of North Carolina at Chapel Hill University of Chicago UNC Lineberger Comprehensive Cancer Center

About

Thomas A. Hensing is an author at NorthShore University HealthSystem specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	1.3K
2	Health Sciences	6	6	164
3	Nursing	2	2	40
4	Public Health	2	2	50
5	Engineering	1	1	67

Thomas A. Hensing

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study Glenwood Goss, Chris J. O’Callaghan, Ian Lorimer, Journal of Clinical Oncology	2013	359
Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research Rogério Lilenbaum, John Cashy, Thomas A. Hensing, Journal of Thoracic Oncology Cancer EpidemiologyMedicineEpidemiology Of CancerOutcomes ResearchLung Cancer Patients	2008	217
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology Don S. Dizon, Lada Krilov, Ezra E.W. Cohen, Journal of Clinical Oncology MedicineCancer ManagementPathologyAmerican SocietyClinical Oncology	2016	212
Treatment of Stage IV Non-small Cell Lung Cancer Mark A. Socinski, Tracey L. Evans, Scott Gettinger, CHEST Journal MedicinePulmonary BlastomaOncologyRadiation OncologyLung Cancer	2013	190
Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer Jyoti D. Patel, Thomas A. Hensing, Alfred Rademaker, Journal of Clinical Oncology	2009	179
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy Robert Eilers, Mona A. Gandhi, Jyoti D. Patel, JNCI Journal of the National Cancer Institute	2009	162
Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial Mark A. Socinski, David E. Morris, Jan Halle, Journal of Clinical Oncology	2004	153
Nanoscale Cellular Changes in Field Carcinogenesis Detected by Partial Wave Spectroscopy Hariharan Subramanian, Hemant K. Roy, Prabhakar Pradhan, Cancer Research	2009	143
Molecularly Targeted Therapies in Non–Small-Cell Lung Cancer Annual Update 2014 Daniel Morgensztern, Meghan Campo, Suzanne E. Dahlberg, Journal of Thoracic Oncology MedicinePharmacologyBronchial NeoplasmTargeted TherapyCancer Treatment	2015	138
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel Thomas A. Hensing, Amy H. Peterman, Michael J. Schell, Cancer	2003	138

Page 1